Guillaume is a clinician-scientist, incoming assistant professor of medicine at the McGill University, and specialist in infectious diseases. He trained in mathematics, clinical medicine, and genetic epidemiology at McGill and the University of Oxford. As part of his research programs, he has successfully led international scientific consortiums and collaborates with researchers around the world. Guillaume is developing 5 Prime Sciences’ pipeline using genetics to translate protein measurements into therapeutic targets.

• 

  Consultants in 5 Prime Sciences

  The best medicines start with the best targets